×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Angioplasty Balloons Market Share

ID: MRFR/HC/8136-HCR
200 Pages
Rahul Gotadki
October 2025

Angioplasty Balloons Market Research Report By Type (Drug-Eluting Balloons, Plain Old Balloons, Scoring Balloons), By Application (Coronary Angioplasty, Peripheral Angioplasty, Renal Angioplasty), By Material (Polymer, Latex, Metal), By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Angioplasty Balloons Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Angioplasty Balloons Market Share Analysis

The Angioplasty Balloons market plays a critical role in interventional cardiology, addressing arterial blockages and restoring blood flow. Companies operating in this market deploy diverse strategies to effectively position themselves, ensuring their angioplasty balloons gain significant market share in the competitive cardiovascular care landscape. A common form of primacy strategy is the perpetual innovation in angioplasty balloon technological domain. Firms spend on research and development, which leads to better product design, alternation in balloon substance as well as the methods of inflation. These improvements could include less rigid and more portable balloons, features for rapid inflation/deflation or a system of upgraded navigability, which can create a noticeable difference in the market because other existing products are unlikely to have these attributes. One of the important strategies include various educational schemes for the health workers especially those practitioners in cardiology. Various companies host seminars, symposiums, workshops on angioplasty balloon technology as the training programs; to bring clinicians to the latest improvement made in angioplasty. The initiatives lead to a larger degree of awareness and adoptions of particular balloon solutions in clinical operations. Affordability is one important market positioning strategy that competitors employ. Firms minimize and re-engineer their manufacturing process to ensure competitive prices for angioplasty balloons while at the same time maintaining high quality. It then follows that cost-effective solutions are attractive to many other healthcare facilities besides the target customers, helping nonte control of market competitiveness. In the framework of innovation-oriented approach to business and development, patient satisfaction weight is high and successful companies emphasize patient-centric communication. They also offer the necessary knowledge, for those medics undergoing angioplasty procedures including advantages of specific balloon technologies. Open communication is important for positive patient-centredness and promotes a sharpened difference in the market, also contributing to customer loyalty. In the modern age of digitalization companies pay special attention to bringing a stronger on line presence and making use of various opportunities provided by digital marketing. This encompasses the provision of informational online sites, social networking interactions, and online training material. Digital platforms promote to be educational hubs where education is enhanced and seen as points of visibility that contribute greatly towards the frequency of adoption of a particular angioplasty balloon product. Offering comprehensive customer support and training services is essential for market positioning. Companies provide ongoing technical support, device training, and regular communication to ensure the optimal use and satisfaction with their angioplasty balloons. This commitment to customer care fosters customer loyalty and positive word-of-mouth referrals.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Angioplasty Balloons Market by 2035?

The projected market valuation of the Angioplasty Balloons Market is expected to reach 5.1 USD Billion by 2035.

What was the overall market valuation of the Angioplasty Balloons Market in 2024?

The overall market valuation of the Angioplasty Balloons Market was 3.38 USD Billion in 2024.

What is the expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035?

The expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035 is 3.81%.

Which segment is projected to have the highest valuation in the Angioplasty Balloons Market by 2035?

The Drug-Eluting Balloons segment is projected to reach a valuation of 2.0 USD Billion by 2035.

What are the key applications of angioplasty balloons in the market?

The key applications include Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, with Coronary Angioplasty projected to reach 2.45 USD Billion by 2035.

Which materials are predominantly used in the production of angioplasty balloons?

The predominant materials include Polymer, Latex, and Metal, with Polymer expected to reach 2.0 USD Billion by 2035.

What is the expected valuation of the Ambulatory Surgical Centers segment by 2035?

The Ambulatory Surgical Centers segment is expected to reach a valuation of 1.25 USD Billion by 2035.

Who are the leading players in the Angioplasty Balloons Market?

The leading players in the Angioplasty Balloons Market include Boston Scientific, Medtronic, and Abbott Laboratories.

What was the valuation of the Scoring Balloons segment in 2024?

The Scoring Balloons segment was valued at 1.03 USD Billion in 2024.

How does the market for Plain Old Balloons compare to Drug-Eluting Balloons by 2035?

By 2035, the Plain Old Balloons segment is projected to reach 1.5 USD Billion, while Drug-Eluting Balloons is expected to reach 2.0 USD Billion.

Market Summary

As per MRFR analysis, the Angioplasty Balloons Market Size was estimated at 3.38 USD Billion in 2024. The Angioplasty Balloons industry is projected to grow from 3.509 USD Billion in 2025 to 5.1 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 3.81 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Angioplasty Balloons Market is poised for growth driven by technological advancements and increasing healthcare investments.

  • North America remains the largest market for angioplasty balloons, reflecting a robust healthcare infrastructure. Asia-Pacific is emerging as the fastest-growing region, fueled by rising healthcare expenditures and population awareness. Drug-eluting balloons dominate the market, while scoring balloons are witnessing rapid growth due to their innovative designs. Technological advancements and the rising prevalence of cardiovascular diseases are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 3.38 (USD Billion)
2035 Market Size 5.1 (USD Billion)
CAGR (2025 - 2035) 3.81%
Largest Regional Market Share in 2024 North America

Major Players

<p>Boston Scientific (US), <a href="https://www.medtronic.com/in-en/healthcare-professionals/products.html">Medtronic </a>(US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cordis (US), Terumo Corporation (JP), Asahi Intecc Co., Ltd. (JP), Cook Medical (US), AngioDynamics (US)</p>

Market Trends

The Angioplasty Balloons Market is currently experiencing a notable evolution, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. The demand for minimally invasive procedures has surged, as healthcare providers and patients alike seek alternatives to traditional surgical methods. This shift is fostering innovation in balloon designs, materials, and delivery systems, which are becoming more sophisticated and tailored to specific patient needs. Furthermore, the growing awareness of preventive healthcare is prompting more individuals to seek early intervention, thereby expanding the market's reach and potential. In addition, regulatory bodies are playing a crucial role in shaping the landscape of the Angioplasty Balloons Market. Stricter guidelines and quality standards are being implemented to ensure patient safety and efficacy of devices. This regulatory environment, while challenging, is likely to encourage manufacturers to invest in research and development, leading to the introduction of novel products. As the market continues to mature, collaboration between industry stakeholders, including healthcare providers, manufacturers, and regulatory agencies, appears essential for fostering innovation and improving patient outcomes.

Technological Advancements

The Angioplasty Balloons Market is witnessing rapid technological advancements, particularly in balloon design and materials. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the effectiveness of procedures, potentially leading to better patient outcomes. These developments may also contribute to reduced recovery times and lower complication rates.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is significantly influencing the Angioplasty Balloons Market. As more individuals are diagnosed with conditions requiring angioplasty, the demand for effective treatment options is likely to rise. This trend underscores the importance of timely interventions and the need for advanced medical devices.

Regulatory Influence

Regulatory bodies are becoming increasingly influential in the Angioplasty Balloons Market. Stricter regulations and quality standards are being established to ensure the safety and efficacy of medical devices. While this may pose challenges for manufacturers, it also encourages innovation and the development of higher-quality products.

Angioplasty Balloons Market Market Drivers

Regulatory Influence on Market Dynamics

Regulatory frameworks play a crucial role in shaping the Angioplasty Balloons Market. Stringent regulations ensure the safety and efficacy of medical devices, including angioplasty balloons. Compliance with these regulations can be a double-edged sword; while they may pose challenges for manufacturers, they also foster innovation and quality improvements. Regulatory bodies are increasingly focusing on post-market surveillance and real-world evidence, which can influence product development and market entry strategies. As companies navigate these regulatory landscapes, the Angioplasty Balloons Market is likely to evolve, with an emphasis on transparency and patient safety. This dynamic environment may lead to the introduction of new products that meet regulatory standards.

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases is a primary driver for the Angioplasty Balloons Market. As populations age and lifestyle-related health issues become more prevalent, the demand for effective treatment options rises. Statistics indicate that cardiovascular diseases remain a leading cause of mortality worldwide, prompting healthcare systems to seek innovative solutions. Angioplasty procedures, facilitated by advanced balloon technologies, are becoming a standard treatment for conditions such as coronary artery disease. This growing patient population necessitates a robust supply of angioplasty balloons, thereby propelling market growth. The Angioplasty Balloons Market is thus positioned to expand as healthcare providers respond to this urgent need.

Growing Investment in Healthcare Infrastructure

Investment in healthcare infrastructure is a significant driver for the Angioplasty Balloons Market. As countries prioritize healthcare improvements, the establishment of advanced medical facilities and the procurement of cutting-edge medical devices become essential. Increased funding for cardiovascular care, particularly in emerging markets, is expected to enhance access to angioplasty procedures. This trend is supported by government initiatives aimed at reducing the burden of cardiovascular diseases. Consequently, the demand for angioplasty balloons is anticipated to rise, as healthcare providers seek to equip their facilities with the latest technologies. The Angioplasty Balloons Market stands to benefit from this influx of investment, potentially leading to enhanced patient care.

Technological Advancements in Angioplasty Balloons

The Angioplasty Balloons Market is experiencing a notable transformation due to rapid technological advancements. Innovations such as drug-eluting balloons and bioresorbable materials are enhancing the efficacy of angioplasty procedures. These advancements not only improve patient outcomes but also reduce the risk of restenosis, a common complication. The introduction of advanced imaging techniques and minimally invasive procedures is further driving the adoption of angioplasty balloons. According to recent data, the market for drug-eluting balloons is projected to grow significantly, indicating a shift towards more effective treatment options. As healthcare providers increasingly adopt these technologies, the Angioplasty Balloons Market is likely to witness substantial growth in the coming years.

Increasing Awareness and Education on Cardiovascular Health

The growing awareness and education surrounding cardiovascular health are pivotal for the Angioplasty Balloons Market. Public health campaigns and educational initiatives are informing populations about the risks associated with cardiovascular diseases and the importance of early intervention. As individuals become more knowledgeable about treatment options, including angioplasty, the demand for these procedures is likely to increase. Healthcare providers are also focusing on patient education, which can lead to higher rates of diagnosis and treatment. This heightened awareness is expected to drive the adoption of angioplasty balloons, as patients seek effective solutions for their cardiovascular issues. The Angioplasty Balloons Market is thus poised for growth as awareness continues to expand.

Market Segment Insights

By Type: Drug-Eluting Balloons (Largest) vs. Scoring Balloons (Fastest-Growing)

<p>In the Angioplasty Balloons Market, Drug-Eluting Balloons command a significant share due to their ability to deliver medication directly to the affected area, thereby reducing the risk of restenosis. Plain Old Balloons, while being a standard choice, cater to a specific segment of patients who may not require advanced therapy. Scoring Balloons are gradually carving out their niche with their ability to provide enhanced vessel modifications, thus complementing the existing offerings in this market.</p>

<p>Drug-Eluting Balloons (Dominant) vs. Scoring Balloons (Emerging)</p>

<p>Drug-Eluting Balloons hold a dominant position in the <a href="https://www.marketresearchfuture.com/reports/angioplasty-balloons-market-9614">Angioplasty </a>Balloons Market due to their unique design that combines angioplasty with localized drug therapy. This has proven effective in reducing restenosis rates, making them a preferred choice among cardiologists. In contrast, Scoring Balloons are an emerging solution that provides mechanical help to opened vessels and encourage positive remodeling of the arteries. Their growth is driven by increasing procedural volume and the need for innovative technologies that ensure patient safety and efficacy, positioning them as a promising alternative to traditional options.</p>

By Application: Coronary Angioplasty (Largest) vs. Peripheral Angioplasty (Fastest-Growing)

<p>In the Angioplasty Balloons Market, the application segment is prominently dominated by coronary angioplasty. This segment holds the majority market share due to the high prevalence of coronary artery diseases and the increasing number of angioplasty procedures globally. Peripheral angioplasty follows closely, showing significant growth as healthcare providers focus on treating peripheral artery diseases, which have become increasingly recognized and treated in recent years.</p>

<p>Coronary Angioplasty (Dominant) vs. Peripheral Angioplasty (Emerging)</p>

<p>Coronary angioplasty remains the dominant segment in the Angioplasty Balloons Market, primarily because of its established use and effectiveness in treating coronary artery blockages. It is widely favored among healthcare professionals and patients for its proven success rates. On the other hand, peripheral angioplasty is an emerging segment that has gained traction due to the rising incidence of peripheral artery disease (PAD). This segment is expected to witness robust growth driven by advancements in balloon technology and increasing awareness about the treatment options available for chronic limb ischemia. The increasing patient population and the need for minimally invasive procedures further support the expansion of this segment.</p>

By Material: Polymer (Largest) vs. Metal (Fastest-Growing)

<p>In the Angioplasty Balloons Market, the material segment showcases a diverse range of options, with polymers leading the share distribution. Polymeric balloons are favored for their flexibility and compliance, making them ideal for various angioplasty procedures. They account for a significant portion of market usage, offering a superior balance of performance and patient safety. On the other hand, metal balloons, although smaller in market share, are gaining traction due to their robustness and ability to maintain shape under high-pressure conditions, making them suitable for specific clinical applications. The growth trends indicate a pronounced shift towards polymer <a href="https://www.marketresearchfuture.com/reports/orthopedic-biomaterial-market-415">materials</a>, driven by technological advancements and increasing demand for minimally invasive procedures. Furthermore, the market for metal balloons is rapidly expanding as they are recognized for their durability and efficacy in challenging anatomical circumstances. As healthcare providers continue to prioritize patient outcomes, the development of advanced polymer formulations and metal balloon designs is expected to accelerate, shaping the competitive landscape of the Angioplasty Balloons Market.</p>

<p>Polymer (Dominant) vs. Metal (Emerging)</p>

<p>Polymer balloons dominate the Angioplasty Balloons Market due to their excellent performance characteristics, including flexibility, compliance, and safety. These attributes enable them to effectively navigate the vascular system while minimizing the risk of vessel trauma. Their adaptability to various angioplasty techniques makes them the preferred choice among healthcare professionals. In contrast, metal balloons represent an emerging segment, characterized by their strength and ability to withstand high pressures. Although they have a smaller market presence, their unique properties are leading to increased adoption in certain scenarios, particularly where durability is essential. The distinction between these materials is critical, as they cater to different clinical needs and influence procedural outcomes.</p>

By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

<p>In the Angioplasty Balloons Market, hospitals represent the largest end-use segment, catering to a significant share of procedures due to their comprehensive facilities and specialized staffing. Ambulatory Surgical Centers (ASCs), although smaller in market share compared to hospitals, are quickly gaining traction, attributed to their efficiency and cost-effectiveness. The growth trends within this segment indicate a strong inclination towards minimally invasive procedures conducted in ASCs, which are seen as a more patient-centric approach. The increasing preference for outpatient services and technological advancements, such as improved balloon designs, are key factors driving the expansion of ASCs in the market.</p>

<p>Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)</p>

<p>Hospitals continue to dominate the Angioplasty Balloons Market due to their extensive infrastructure, broader range of services, and 24/7 availability of healthcare professionals. They are well-equipped to handle complex cases and offer comprehensive post-procedure care, making them a preferred choice for critical interventions. On the other hand, Ambulatory Surgical Centers are emerging as a popular alternative owing to their focus on outpatient care, lower costs, and increased patient convenience. ASCs leverage advancements in medical technology and a streamlined approach to procedures, which appeals to a growing patient base opting for less invasive surgical options. This shift in preferences is reshaping the landscape of the angioplasty balloons market.</p>

Get more detailed insights about Angioplasty Balloons Market Research Report - Forecast till 2035

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for angioplasty balloons, holding approximately 45% of the global market share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on innovation. Regulatory support from agencies like the FDA facilitates rapid product approvals, enhancing market dynamics. The demand for minimally invasive procedures is also on the rise, further propelling market growth. The United States is the leading country in this region, with major players such as Boston Scientific, Medtronic, and Abbott Laboratories dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships among key players. Canada also contributes significantly to the market, focusing on improving healthcare access and patient outcomes, thereby supporting the overall growth of the angioplasty balloon market.

Europe : Emerging Regulatory Frameworks

Europe is the second-largest market for angioplasty balloons, accounting for approximately 30% of the global market share. The region benefits from a robust healthcare system and increasing investments in medical technology. Regulatory frameworks, such as the Medical Device Regulation (MDR), are evolving to ensure patient safety and product efficacy, which in turn drives market growth. The rising incidence of cardiovascular diseases and an aging population further fuel demand for angioplasty procedures. Leading countries in Europe include Germany, France, and the UK, where key players like B. Braun Melsungen AG and Cordis are actively involved. The competitive landscape is marked by innovation and collaboration among manufacturers to enhance product offerings. The presence of advanced research institutions also supports the development of cutting-edge technologies in the angioplasty balloon market.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is witnessing rapid growth in the angioplasty balloons market, driven by increasing healthcare expenditure and a rising prevalence of cardiovascular diseases. The region holds approximately 20% of the global market share, with countries like Japan and China leading the charge. Government initiatives aimed at improving healthcare infrastructure and access to advanced medical technologies are significant growth drivers. The demand for minimally invasive procedures is also on the rise, contributing to market expansion. Japan is a key player in this market, with companies like Terumo Corporation and Asahi Intecc Co., Ltd. leading the way. The competitive landscape is characterized by a mix of local and international players, fostering innovation and collaboration. Additionally, the growing awareness of cardiovascular health among the population is expected to further boost the demand for angioplasty balloons in the region.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging as a potential market for angioplasty balloons, holding approximately 5% of the global market share. The growth is driven by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Governments are focusing on enhancing healthcare infrastructure and access to advanced medical technologies, which are crucial for market development. The demand for angioplasty procedures is expected to rise as awareness of cardiovascular health improves. Leading countries in this region include South Africa and the UAE, where healthcare reforms are paving the way for advanced medical solutions. The competitive landscape is still developing, with opportunities for both local and international players to enter the market. Key players are beginning to explore partnerships and collaborations to expand their reach in this untapped market.

Key Players and Competitive Insights

The Angioplasty Balloons Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market positions. Boston Scientific (US) emphasizes the development of advanced balloon technologies, while Medtronic (US) is leveraging its extensive distribution network to penetrate emerging markets. Abbott Laboratories (US) appears to be concentrating on expanding its product portfolio through acquisitions, thereby enhancing its competitive edge in this rapidly evolving sector.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure is moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and innovations, fostering a competitive environment where companies must continuously adapt to maintain their market share.

In August 2025, Boston Scientific (US) announced the launch of its latest drug-coated balloon, which is designed to improve patient outcomes in complex coronary interventions. This strategic move not only reinforces Boston Scientific's commitment to innovation but also positions the company to capture a larger share of the growing market for advanced angioplasty solutions. The introduction of this product is expected to enhance procedural efficiency and patient safety, thereby solidifying the company's reputation as a leader in the field.

In September 2025, Medtronic (US) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its angioplasty balloon offerings. This collaboration aims to enhance patient engagement and streamline post-procedural care, reflecting a broader trend towards digital health solutions. By incorporating telehealth features, Medtronic (US) is likely to improve patient outcomes and satisfaction, which could translate into increased market share in the competitive landscape.

In July 2025, Abbott Laboratories (US) completed the acquisition of a smaller medical device company specializing in innovative balloon technologies. This acquisition is indicative of Abbott's strategy to bolster its product offerings and expand its technological capabilities. By integrating these new technologies, Abbott Laboratories (US) is poised to enhance its competitive positioning and respond more effectively to the evolving needs of healthcare providers and patients.

As of October 2025, the Angioplasty Balloons Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence in product development. Strategic alliances are becoming increasingly important, as companies seek to leverage complementary strengths to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological advancements, supply chain reliability, and enhanced patient outcomes. This shift underscores the necessity for companies to invest in research and development to stay ahead in a market that is rapidly changing.

Key Companies in the Angioplasty Balloons Market market include

Industry Developments

Recent developments in the Angioplasty Balloons Market indicate a significant increase in demand driven by the rise in cardiovascular diseases globally.

Companies like Medtronic Cardiovascular and Boston Scientific have been focusing on enhancing their product offerings to include advanced balloon technologies that improve patient outcomes.

Notably, in September 2023, Abbott Laboratories announced the launch of a new line of drug-eluting balloons, aimed at providing more effective treatment options for patients suffering from coronary artery disease.

Furthermore, a strategic merger was confirmed in August 2023, where Philips Healthcare acquired a small biotechnology firm specializing in innovative angioplasty balloon technologies, thereby augmenting its portfolio.

Meanwhile, Asahi Intecc reported a steady growth in market valuation due to the increasing adoption of minimally invasive procedures, reflecting a broader industry trend aligning with healthcare advancements.

In recent years, significant investments led by Johnson and Johnson and Cook Medical into Research and Development activities have aimed to drive innovation in angioplasty balloon designs, contributing to the overall market growth.

These advancements and corporate strategies highlight the evolving landscape of the Angioplasty Balloons Market as companies look to capture market share through technological improvements and strategic collaborations.

 

Future Outlook

Angioplasty Balloons Market Future Outlook

<p>The Angioplasty Balloons Market is projected to grow at a 3.81% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditures.</p>

New opportunities lie in:

  • <p>Development of biodegradable angioplasty balloons for enhanced patient safety.</p>
  • <p>Expansion into emerging markets with tailored product offerings.</p>
  • <p>Integration of smart technology for real-time monitoring during procedures.</p>

<p>By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.</p>

Market Segmentation

Angioplasty Balloons Market Type Outlook

  • Drug-Eluting Balloons
  • Plain Old Balloons
  • Scoring Balloons

Angioplasty Balloons Market End Use Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

Angioplasty Balloons Market Material Outlook

  • Polymer
  • Latex
  • Metal

Angioplasty Balloons Market Application Outlook

  • Coronary Angioplasty
  • Peripheral Angioplasty
  • Renal Angioplasty

Report Scope

MARKET SIZE 2024 3.38(USD Billion)
MARKET SIZE 2025 3.509(USD Billion)
MARKET SIZE 2035 5.1(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.81% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Market analysis in progress
Segments Covered Market segmentation analysis in progress
Key Market Opportunities Advancements in biodegradable materials enhance safety and efficacy in the Angioplasty Balloons Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the angioplasty balloons market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Angioplasty Balloons Market by 2035?

The projected market valuation of the Angioplasty Balloons Market is expected to reach 5.1 USD Billion by 2035.

What was the overall market valuation of the Angioplasty Balloons Market in 2024?

The overall market valuation of the Angioplasty Balloons Market was 3.38 USD Billion in 2024.

What is the expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035?

The expected CAGR for the Angioplasty Balloons Market during the forecast period 2025 - 2035 is 3.81%.

Which segment is projected to have the highest valuation in the Angioplasty Balloons Market by 2035?

The Drug-Eluting Balloons segment is projected to reach a valuation of 2.0 USD Billion by 2035.

What are the key applications of angioplasty balloons in the market?

The key applications include Coronary Angioplasty, Peripheral Angioplasty, and Renal Angioplasty, with Coronary Angioplasty projected to reach 2.45 USD Billion by 2035.

Which materials are predominantly used in the production of angioplasty balloons?

The predominant materials include Polymer, Latex, and Metal, with Polymer expected to reach 2.0 USD Billion by 2035.

What is the expected valuation of the Ambulatory Surgical Centers segment by 2035?

The Ambulatory Surgical Centers segment is expected to reach a valuation of 1.25 USD Billion by 2035.

Who are the leading players in the Angioplasty Balloons Market?

The leading players in the Angioplasty Balloons Market include Boston Scientific, Medtronic, and Abbott Laboratories.

What was the valuation of the Scoring Balloons segment in 2024?

The Scoring Balloons segment was valued at 1.03 USD Billion in 2024.

How does the market for Plain Old Balloons compare to Drug-Eluting Balloons by 2035?

By 2035, the Plain Old Balloons segment is projected to reach 1.5 USD Billion, while Drug-Eluting Balloons is expected to reach 2.0 USD Billion.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Type (USD Billion)
      1. Drug-Eluting Balloons
      2. Plain Old Balloons
      3. Scoring Balloons
    2. Healthcare, BY Application (USD Billion)
      1. Coronary Angioplasty
      2. Peripheral Angioplasty
      3. Renal Angioplasty
    3. Healthcare, BY Material (USD Billion)
      1. Polymer
      2. Latex
      3. Metal
    4. Healthcare, BY End Use (USD Billion)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Cardiac Catheterization Laboratories
    5. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Boston Scientific (US)
      2. Medtronic (US)
      3. Abbott Laboratories (US)
      4. B. Braun Melsungen AG (DE)
      5. Cordis (US)
      6. Terumo Corporation (JP)
      7. Asahi Intecc Co., Ltd. (JP)
      8. Cook Medical (US)
      9. AngioDynamics (US)
    3. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    4. MARKET SYNOPSIS
    5. NORTH AMERICA MARKET ANALYSIS
    6. US MARKET ANALYSIS BY TYPE
    7. US MARKET ANALYSIS BY APPLICATION
    8. US MARKET ANALYSIS BY MATERIAL
    9. US MARKET ANALYSIS BY END USE
    10. CANADA MARKET ANALYSIS BY TYPE
    11. CANADA MARKET ANALYSIS BY APPLICATION
    12. CANADA MARKET ANALYSIS BY MATERIAL
    13. CANADA MARKET ANALYSIS BY END USE
    14. EUROPE MARKET ANALYSIS
    15. GERMANY MARKET ANALYSIS BY TYPE
    16. GERMANY MARKET ANALYSIS BY APPLICATION
    17. GERMANY MARKET ANALYSIS BY MATERIAL
    18. GERMANY MARKET ANALYSIS BY END USE
    19. UK MARKET ANALYSIS BY TYPE
    20. UK MARKET ANALYSIS BY APPLICATION
    21. UK MARKET ANALYSIS BY MATERIAL
    22. UK MARKET ANALYSIS BY END USE
    23. FRANCE MARKET ANALYSIS BY TYPE
    24. FRANCE MARKET ANALYSIS BY APPLICATION
    25. FRANCE MARKET ANALYSIS BY MATERIAL
    26. FRANCE MARKET ANALYSIS BY END USE
    27. RUSSIA MARKET ANALYSIS BY TYPE
    28. RUSSIA MARKET ANALYSIS BY APPLICATION
    29. RUSSIA MARKET ANALYSIS BY MATERIAL
    30. RUSSIA MARKET ANALYSIS BY END USE
    31. ITALY MARKET ANALYSIS BY TYPE
    32. ITALY MARKET ANALYSIS BY APPLICATION
    33. ITALY MARKET ANALYSIS BY MATERIAL
    34. ITALY MARKET ANALYSIS BY END USE
    35. SPAIN MARKET ANALYSIS BY TYPE
    36. SPAIN MARKET ANALYSIS BY APPLICATION
    37. SPAIN MARKET ANALYSIS BY MATERIAL
    38. SPAIN MARKET ANALYSIS BY END USE
    39. REST OF EUROPE MARKET ANALYSIS BY TYPE
    40. REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    41. REST OF EUROPE MARKET ANALYSIS BY MATERIAL
    42. REST OF EUROPE MARKET ANALYSIS BY END USE
    43. APAC MARKET ANALYSIS
    44. CHINA MARKET ANALYSIS BY TYPE
    45. CHINA MARKET ANALYSIS BY APPLICATION
    46. CHINA MARKET ANALYSIS BY MATERIAL
    47. CHINA MARKET ANALYSIS BY END USE
    48. INDIA MARKET ANALYSIS BY TYPE
    49. INDIA MARKET ANALYSIS BY APPLICATION
    50. INDIA MARKET ANALYSIS BY MATERIAL
    51. INDIA MARKET ANALYSIS BY END USE
    52. JAPAN MARKET ANALYSIS BY TYPE
    53. JAPAN MARKET ANALYSIS BY APPLICATION
    54. JAPAN MARKET ANALYSIS BY MATERIAL
    55. JAPAN MARKET ANALYSIS BY END USE
    56. SOUTH KOREA MARKET ANALYSIS BY TYPE
    57. SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    58. SOUTH KOREA MARKET ANALYSIS BY MATERIAL
    59. SOUTH KOREA MARKET ANALYSIS BY END USE
    60. MALAYSIA MARKET ANALYSIS BY TYPE
    61. MALAYSIA MARKET ANALYSIS BY APPLICATION
    62. MALAYSIA MARKET ANALYSIS BY MATERIAL
    63. MALAYSIA MARKET ANALYSIS BY END USE
    64. THAILAND MARKET ANALYSIS BY TYPE
    65. THAILAND MARKET ANALYSIS BY APPLICATION
    66. THAILAND MARKET ANALYSIS BY MATERIAL
    67. THAILAND MARKET ANALYSIS BY END USE
    68. INDONESIA MARKET ANALYSIS BY TYPE
    69. INDONESIA MARKET ANALYSIS BY APPLICATION
    70. INDONESIA MARKET ANALYSIS BY MATERIAL
    71. INDONESIA MARKET ANALYSIS BY END USE
    72. REST OF APAC MARKET ANALYSIS BY TYPE
    73. REST OF APAC MARKET ANALYSIS BY APPLICATION
    74. REST OF APAC MARKET ANALYSIS BY MATERIAL
    75. REST OF APAC MARKET ANALYSIS BY END USE
    76. SOUTH AMERICA MARKET ANALYSIS
    77. BRAZIL MARKET ANALYSIS BY TYPE
    78. BRAZIL MARKET ANALYSIS BY APPLICATION
    79. BRAZIL MARKET ANALYSIS BY MATERIAL
    80. BRAZIL MARKET ANALYSIS BY END USE
    81. MEXICO MARKET ANALYSIS BY TYPE
    82. MEXICO MARKET ANALYSIS BY APPLICATION
    83. MEXICO MARKET ANALYSIS BY MATERIAL
    84. MEXICO MARKET ANALYSIS BY END USE
    85. ARGENTINA MARKET ANALYSIS BY TYPE
    86. ARGENTINA MARKET ANALYSIS BY APPLICATION
    87. ARGENTINA MARKET ANALYSIS BY MATERIAL
    88. ARGENTINA MARKET ANALYSIS BY END USE
    89. REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    90. REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    91. REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
    92. REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
    93. MEA MARKET ANALYSIS
    94. GCC COUNTRIES MARKET ANALYSIS BY TYPE
    95. GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    96. GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
    97. GCC COUNTRIES MARKET ANALYSIS BY END USE
    98. SOUTH AFRICA MARKET ANALYSIS BY TYPE
    99. SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    100. SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
    101. SOUTH AFRICA MARKET ANALYSIS BY END USE
    102. REST OF MEA MARKET ANALYSIS BY TYPE
    103. REST OF MEA MARKET ANALYSIS BY APPLICATION
    104. REST OF MEA MARKET ANALYSIS BY MATERIAL
    105. REST OF MEA MARKET ANALYSIS BY END USE
    106. KEY BUYING CRITERIA OF HEALTHCARE
    107. RESEARCH PROCESS OF MRFR
    108. DRO ANALYSIS OF HEALTHCARE
    109. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    110. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    111. SUPPLY / VALUE CHAIN: HEALTHCARE
    112. HEALTHCARE, BY TYPE, 2024 (% SHARE)
    113. HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    114. HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    115. HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    116. HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
    117. HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
    118. HEALTHCARE, BY END USE, 2024 (% SHARE)
    119. HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
    120. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    121. LIST OF ASSUMPTIONS
    122. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    123. US MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    124. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    125. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    126. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    127. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    128. France MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    129. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    130. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    131. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    132. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    133. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    134. China MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    135. India MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    136. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    137. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    138. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    139. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    140. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    141. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    142. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    143. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    144. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    145. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    146. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    147. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    148. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    149. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    150. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY TYPE, 2025-2035 (USD Billion)
      2. BY APPLICATION, 2025-2035 (USD Billion)
      3. BY MATERIAL, 2025-2035 (USD Billion)
      4. BY END USE, 2025-2035 (USD Billion)
    151. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    152. ACQUISITION/PARTNERSHIP

Angioplasty Balloons Market Segmentation

Angioplasty Balloons Market By Type (USD Billion, 2019-2035)

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

Angioplasty Balloons Market By Application (USD Billion, 2019-2035)

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

Angioplasty Balloons Market By Material (USD Billion, 2019-2035)

Polymer

Latex

Metal

Angioplasty Balloons Market By End Use (USD Billion, 2019-2035)

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

Angioplasty Balloons Market By Regional (USD Billion, 2019-2035)

North America

Europe

South America

Asia Pacific

Middle East and Africa

Angioplasty Balloons Market Regional Outlook (USD Billion, 2019-2035)

North America Outlook (USD Billion, 2019-2035)

North America Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

North America Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

North America Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

North America Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

North America Angioplasty Balloons Market by Regional Type

US

Canada

US Outlook (USD Billion, 2019-2035)

US Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

US Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

US Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

US Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

CANADA Outlook (USD Billion, 2019-2035)

CANADA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

CANADA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

CANADA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

CANADA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

Europe Outlook (USD Billion, 2019-2035)

Europe Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

Europe Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

Europe Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

Europe Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

Europe Angioplasty Balloons Market by Regional Type

Germany

UK

France

Russia

Italy

Spain

Rest of Europe

GERMANY Outlook (USD Billion, 2019-2035)

GERMANY Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

GERMANY Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

GERMANY Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

GERMANY Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

UK Outlook (USD Billion, 2019-2035)

UK Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

UK Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

UK Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

UK Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

FRANCE Outlook (USD Billion, 2019-2035)

FRANCE Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

FRANCE Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

FRANCE Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

FRANCE Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

RUSSIA Outlook (USD Billion, 2019-2035)

RUSSIA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

RUSSIA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

RUSSIA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

RUSSIA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

ITALY Outlook (USD Billion, 2019-2035)

ITALY Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

ITALY Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

ITALY Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

ITALY Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

SPAIN Outlook (USD Billion, 2019-2035)

SPAIN Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

SPAIN Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

SPAIN Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

SPAIN Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

REST OF EUROPE Outlook (USD Billion, 2019-2035)

REST OF EUROPE Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

REST OF EUROPE Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

REST OF EUROPE Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

REST OF EUROPE Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

APAC Outlook (USD Billion, 2019-2035)

APAC Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

APAC Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

APAC Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

APAC Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

APAC Angioplasty Balloons Market by Regional Type

China

India

Japan

South Korea

Malaysia

Thailand

Indonesia

Rest of APAC

CHINA Outlook (USD Billion, 2019-2035)

CHINA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

CHINA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

CHINA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

CHINA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

INDIA Outlook (USD Billion, 2019-2035)

INDIA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

INDIA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

INDIA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

INDIA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

JAPAN Outlook (USD Billion, 2019-2035)

JAPAN Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

JAPAN Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

JAPAN Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

JAPAN Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

SOUTH KOREA Outlook (USD Billion, 2019-2035)

SOUTH KOREA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

SOUTH KOREA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

SOUTH KOREA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

SOUTH KOREA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

MALAYSIA Outlook (USD Billion, 2019-2035)

MALAYSIA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

MALAYSIA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

MALAYSIA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

MALAYSIA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

THAILAND Outlook (USD Billion, 2019-2035)

THAILAND Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

THAILAND Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

THAILAND Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

THAILAND Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

INDONESIA Outlook (USD Billion, 2019-2035)

INDONESIA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

INDONESIA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

INDONESIA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

INDONESIA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

REST OF APAC Outlook (USD Billion, 2019-2035)

REST OF APAC Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

REST OF APAC Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

REST OF APAC Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

REST OF APAC Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

South America Outlook (USD Billion, 2019-2035)

South America Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

South America Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

South America Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

South America Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

South America Angioplasty Balloons Market by Regional Type

Brazil

Mexico

Argentina

Rest of South America

BRAZIL Outlook (USD Billion, 2019-2035)

BRAZIL Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

BRAZIL Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

BRAZIL Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

BRAZIL Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

MEXICO Outlook (USD Billion, 2019-2035)

MEXICO Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

MEXICO Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

MEXICO Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

MEXICO Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

ARGENTINA Outlook (USD Billion, 2019-2035)

ARGENTINA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

ARGENTINA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

ARGENTINA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

ARGENTINA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

REST OF SOUTH AMERICA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

REST OF SOUTH AMERICA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

REST OF SOUTH AMERICA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

REST OF SOUTH AMERICA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

MEA Outlook (USD Billion, 2019-2035)

MEA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

MEA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

MEA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

MEA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

MEA Angioplasty Balloons Market by Regional Type

GCC Countries

South Africa

Rest of MEA

GCC COUNTRIES Outlook (USD Billion, 2019-2035)

GCC COUNTRIES Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

GCC COUNTRIES Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

GCC COUNTRIES Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

GCC COUNTRIES Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

SOUTH AFRICA Outlook (USD Billion, 2019-2035)

SOUTH AFRICA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

SOUTH AFRICA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

SOUTH AFRICA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

SOUTH AFRICA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

REST OF MEA Outlook (USD Billion, 2019-2035)

REST OF MEA Angioplasty Balloons Market by Type

Drug-Eluting Balloons

Plain Old Balloons

Scoring Balloons

REST OF MEA Angioplasty Balloons Market by Application Type

Coronary Angioplasty

Peripheral Angioplasty

Renal Angioplasty

REST OF MEA Angioplasty Balloons Market by Material Type

Polymer

Latex

Metal

REST OF MEA Angioplasty Balloons Market by End Use Type

Hospitals

Ambulatory Surgical Centers

Cardiac Catheterization Laboratories

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓